Hippocampus activity during visual and real-world exploration
Official title: Human Hippocampal Oscillations During Visuomotor Exploration
Run by NYU Langone Health · NCT07224191 · Data updated 2026-11-12
The team will test whether hippocampal activity changes with eye movements during virtual visual exploration and real-world walking in adults with epilepsy and healthy volunteers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | February 25, 2026 |
| Main results expected | October 8, 2028 |
| Study ends | October 8, 2028 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT07224191 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–70 who can give informed consent and either have implanted hippocampal depth electrodes for presurgical monitoring or an RNS device with hippocampal leads (with IQ≥80), or are healthy adults able to walk and wear recording equipment.
✕Probably not a fit
Patients with recent generalized tonic‑clonic seizures, active substance use within one week, legal blindness, pregnancy, inability to walk or give consent, or who are within five months of RNS implantation are unlikely to be eligible or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In one arm, surgical epilepsy patients with high-resolution intracranial EEG will view 10–15 panoramic environments using AR/VR while eye movements and head turns are tracked and synchronized with neural recordings. In a second arm, epilepsy patients implanted with responsive neurostimulators (RNS) and healthy controls will walk through distinct rooms while wearing high-density EEG, eye-tracking glasses, and motion sensors to capture ambulatory exploration. Data from hippocampal iEEG, RNS recordings, hdEEG, eye tracking, and motion sensors will be time-synchronized offline to analyze neural activity before and after saccades and under different cognitive loads. Analyses will focus on hippocampal oscillations and single-unit activity along the hippocampal axis and their relationships to visuomotor behavior.
Why it matters
Potential benefit: If successful, this work could improve understanding of memory-related hippocampal dynamics and help refine mapping or neuromodulation targets for epilepsy and cognitive dysfunction.
How similar studies have gone: Previous intracranial EEG and eye‑tracking work has linked hippocampal activity to saccades, but combining ambulatory RNS recordings with synchronized hdEEG and eye-tracking in real-world environments is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All subjects: * Adults (18-70 years) * Able to provide informed consent Aim 1: Surgical epilepsy patients' inclusion criteria * Implanted hippocampal depth electrodes for Stage 1 epilepsy surgery * MMSE\>=24 Aim 2: RNS patients Inclusion criteria * Implanted RNS device with at least one hippocampal depth electrode * At least 5 months post-implantation to avoid the post-implant effect * Have a relatively low number of seizures, defined as \<1 generalized tonic-clonic or other seizure with potential to fall or cause injury per month * Able to walk and wear research equipment without assistance * MMSE\>=24 Aim 2: Healthy Control Inclusion criteria • Able to walk and wear research equipment without assistance Exclusion Criteria: RNS patients, Aim 2: • Any generalized tonic-clonic seizure within the last week All subjects: * Legally blind * Smoking tobacco, marijuana, recreational drugs or alcohol use within 1 week of cognitive testing * Unable to give informed consent * Pregnancy
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Anli Liu, MD, MA — NYU Langone Health
- Study coordinator: Anli Liu, MD, MA
- Email: Anli.Liu@nyulangone.org
- Phone: (929) 455-2323
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Advanced 7T fMRI for brain function in epilepsy and brain injuries
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.